mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletion.

[1]  D. Gilliland,et al.  Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice. , 2010, Blood.

[2]  M. Loda,et al.  Differential p53-Independent Outcomes of p19Arf Loss in Oncogenesis , 2009, Science Signaling.

[3]  L. Chin,et al.  High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. , 2009, Blood.

[4]  S. Carmichael,et al.  Pten Deletion in Adult Neural Stem/Progenitor Cells Enhances Constitutive Neurogenesis , 2009, The Journal of Neuroscience.

[5]  D. Guertin,et al.  mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice. , 2009, Cancer cell.

[6]  R. Arceci.  PML targeting eradicates quiescent leukaemia-initiating cells , 2009 .

[7]  David A. Williams,et al.  mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization , 2008, Proceedings of the National Academy of Sciences.

[8]  Yang Liu,et al.  TSC–mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species , 2008, The Journal of experimental medicine.

[9]  L. Cantley,et al.  PI3K pathway alterations in cancer: variations on a theme , 2008, Oncogene.

[10]  Sathish Kumar Mungamuri,et al.  Foxo3 Is Essential for the Regulation of Ataxia Telangiectasia Mutated and Oxidative Stress-mediated Homeostasis of Hematopoietic Stem Cells* , 2008, Journal of Biological Chemistry.

[11]  M. Clarke,et al.  Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors , 2008, Nature.

[12]  S. Morrison,et al.  CD150- cells are transiently reconstituting multipotent progenitors with little or no stem cell activity. , 2008, Blood.

[13]  K. Miyamoto,et al.  Foxo3a is essential for maintenance of the hematopoietic stem cell pool , 2009 .

[14]  A. Strasser,et al.  How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? , 2007, Cell Death and Differentiation.

[15]  David M Sabatini,et al.  Defining the role of mTOR in cancer. , 2007, Cancer cell.

[16]  Lewis C. Cantley,et al.  AKT/PKB Signaling: Navigating Downstream , 2007, Cell.

[17]  S. Armstrong,et al.  FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress , 2007, Cell.

[18]  S. Morrison,et al.  Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells , 2006, Nature.

[19]  Xi C. He,et al.  PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention , 2006, Nature.

[20]  D. Sabatini,et al.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. , 2006, Molecular cell.

[21]  Keisuke Ito,et al.  Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells , 2006, Nature Medicine.

[22]  Hong Chang,et al.  Analysis of PTEN deletions and mutations in multiple myeloma. , 2006, Leukemia research.

[23]  M. Hall,et al.  TOR Signaling in Growth and Metabolism , 2006, Cell.

[24]  D. Geschwind,et al.  PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Jason A. Koutcher,et al.  Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.

[26]  S. Morrison,et al.  Supplemental Experimental Procedures , 2022 .

[27]  Tak W. Mak,et al.  Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells , 2004, Nature.

[28]  I. Gout,et al.  The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins , 2004, The Journal of cell biology.

[29]  K. Inoki,et al.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.

[30]  I. Weissman,et al.  Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Trumpp,et al.  Negative Regulation of Neural Stem/Progenitor Cell Proliferation by the Pten Tumor Suppressor Gene in Vivo , 2001, Science.

[32]  Charles J. Sherr,et al.  The INK4a/ARF network in tumour suppression , 2001, Nature Reviews Molecular Cell Biology.

[33]  D. Carrasco,et al.  Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis , 2001, Nature.

[34]  P. Guldberg,et al.  Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders , 2000, European journal of haematology.

[35]  Pier Paolo Pandolfi,et al.  The Multiple Roles of PTEN in Tumor Suppression , 2000, Cell.

[36]  T. Hunter,et al.  Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[37]  H. Wu,et al.  PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[39]  S. Lowe,et al.  Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. , 1998, Genes & development.

[40]  J L Cleveland,et al.  Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. , 1998, Genes & development.

[41]  S. Lowe,et al.  E1A signaling to p53 involves the p19(ARF) tumor suppressor. , 1998, Genes & development.

[42]  Tomohiko Maehama,et al.  The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.

[43]  M. Raffeld,et al.  PTEN gene alterations in lymphoid neoplasms. , 1998, Blood.

[44]  Richard A. Ashmun,et al.  Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF , 1997, Cell.

[45]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[46]  L. Chin,et al.  Role of the INK4a Locus in Tumor Suppression and Cell Mortality , 1996, Cell.

[47]  M Aguet,et al.  Inducible gene targeting in mice , 1995, Science.

[48]  R. Weinberg,et al.  Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.